Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-May-24 7:00 PM View:  | EXACT Sciences Corp. (EXAS) | 01-May-24 | Sale (Planned) | 1,155 | $60.15 | $69,473.20 | (< 1%) 1.21M to 1.21M | |
| 02-May-24 7:00 PM View: | EXACT Sciences Corp. (EXAS) | 30-Apr-24 | Grant | 3,197 | $6.65 | $21,254.20 | < 1% 1.2M to 1.21M | |
| 04-Mar-24 8:38 PM View: | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Planned Option Sale | 8,271 | $59.32 | $490,636.00 | (< 1%) 1.36M to 1.35M | |
| 04-Mar-24 8:38 PM View: | EXACT Sciences Corp. (EXAS) | 29-Feb-24 | Option Exercise | 18,143 | -- | -- | 1% 1.34M to 1.36M | |
| 28-Feb-24 7:35 PM View: | EXACT Sciences Corp. (EXAS) | 27-Feb-24 | Planned Option Sale | 6,263 | $56.89 | $356,302.00 | (< 1%) 1.35M to 1.34M | |
| 28-Feb-24 7:35 PM View: | EXACT Sciences Corp. (EXAS) | 26-Feb-24 | Option Exercise | 13,181 | -- | -- | < 1% 1.33M to 1.35M | |
| 26-Feb-24 5:00 PM View: | EXACT Sciences Corp. (EXAS) | 23-Feb-24 | Payment of Exercise | 61,560 | $57.53 | $3,541,550.00 | (4%) 1.39M to 1.33M | |
| 26-Feb-24 5:00 PM View: | EXACT Sciences Corp. (EXAS) | 23-Feb-24 | Option Exercise | 102,837 | $13.96 | $1,435,600.00 | 8% 1.29M to 1.39M | |
| 23-Feb-24 7:59 PM View: | EXACT Sciences Corp. (EXAS) | 22-Feb-24 | Sale (Planned) | 11,565 | $59.78 | $691,356.00 | (< 1%) 1.3M to 1.29M | |
| 23-Feb-24 7:59 PM View: | EXACT Sciences Corp. (EXAS) | 21-Feb-24 | Grant | 23,238 | -- | -- | 2% 1.28M to 1.3M | |
| 22-Feb-24 7:37 PM View: | EXACT Sciences Corp. (EXAS) | 21-Feb-24 | Planned Option Sale | 4,975 | $61.50 | $305,962.00 | (< 1%) 1.28M to 1.28M | |
| 22-Feb-24 7:37 PM View: | EXACT Sciences Corp. (EXAS) | 20-Feb-24 | Option Exercise | 10,374 | -- | -- | < 1% 1.27M to 1.28M | |
| 16-Feb-24 6:22 PM View: | EXACT Sciences Corp. (EXAS) | 15-Feb-24 | Planned Option Sale | 14,791 | $61.43 | $908,611.00 | (1%) 1.29M to 1.27M | |
| 16-Feb-24 6:22 PM View: | EXACT Sciences Corp. (EXAS) | 14-Feb-24 | Option Exercise | 31,133 | -- | -- | 2% 1.26M to 1.29M | |
| 16-Feb-24 6:22 PM View: | EXACT Sciences Corp. (EXAS) | 01-May-23 | Grant | 709 | $30.02 | $21,284.20 | < 1% 1.26M to 1.26M | |
| 08-Mar-23 8:05 PM View: | Adaptive Biotechnologies Corp (ADPT) | 06-Mar-23 | Grant | 14,775 | -- | -- | 180% 8.19K to 22.97K | |
| 01-Mar-23 5:15 PM View: | EXACT Sciences Corp. (EXAS) | 28-Feb-23 | Planned Option Sale | 10,416 | $61.12 | $636,626.00 | (< 1%) 1.27M to 1.26M | |
| 01-Mar-23 5:15 PM View: | EXACT Sciences Corp. (EXAS) | 27-Feb-23 | Option Exercise | 22,492 | -- | -- | 2% 1.24M to 1.27M | |
| 23-Feb-23 4:35 PM View: | EXACT Sciences Corp. (EXAS) | 22-Feb-23 | Planned Option Sale | 4,764 | $62.72 | $298,798.00 | (< 1%) 1.25M to 1.24M | |
| 23-Feb-23 4:35 PM View: | EXACT Sciences Corp. (EXAS) | 21-Feb-23 | Option Exercise | 10,374 | -- | -- | < 1% 1.24M to 1.25M | |
| 16-Feb-23 5:05 PM View: | EXACT Sciences Corp. (EXAS) | 15-Feb-23 | Planned Option Sale | 14,617 | $65.59 | $958,729.00 | (1%) 1.25M to 1.24M | |
| 16-Feb-23 5:05 PM View: | EXACT Sciences Corp. (EXAS) | 14-Feb-23 | Option Exercise | 31,132 | -- | -- | 3% 1.22M to 1.25M | |
| 14-Feb-23 5:40 PM View: | EXACT Sciences Corp. (EXAS) | 13-Feb-23 | Planned Option Sale | 4,527 | $64.55 | $292,218.00 | (< 1%) 1.23M to 1.22M | |
| 14-Feb-23 5:40 PM View: | EXACT Sciences Corp. (EXAS) | 10-Feb-23 | Option Exercise | 9,705 | -- | -- | < 1% 1.22M to 1.23M | |
| 16-Aug-22 7:02 PM View: | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 62,318 | -- | -- | (100%) 62.32K to 0 | |
| 06-Jul-22 4:11 PM View: | EXACT Sciences Corp. (EXAS) | 01-Jul-22 | Sale | 7 | $40.75 | $285.25 | (< 1%) 1.22M to 1.22M | |
| 05-Jul-22 5:02 PM View: | Epizyme, Inc. (EPZM) | 30-Jun-22 | Grant | 10,204 | $1.47 | $14,999.90 | 20% 52.11K to 62.32K | |
| 19-May-22 4:26 PM View: | Epizyme, Inc. (EPZM) | 17-May-22 | Grant | 8,994 | -- | -- | 21% 43.12K to 52.11K | |
| 06-Jul-22 4:11 PM View: | EXACT Sciences Corp. (EXAS) | 02-May-22 | Grant | 328 | $47.41 | $15,550.50 | < 1% 1.22M to 1.22M | |
| 01-Apr-22 5:30 PM View: | Epizyme, Inc. (EPZM) | 31-Mar-22 | Grant | 13,043 | $1.15 | $14,999.40 | 43% 30.08K to 43.12K | |
| 18-Mar-22 4:22 PM View: | EXACT Sciences Corp. (EXAS) | 17-Mar-22 | Option Exercise | 236,622 | $6.38 | $1,509,570.00 | 24% 979.3K to 1.22M | |
| 02-Mar-22 5:28 PM View: | EXACT Sciences Corp. (EXAS) | 01-Mar-22 | Planned Option Sale | 14,299 | $76.69 | $1,096,590.00 | (1%) 993.59K to 979.29K | |
| 02-Mar-22 5:28 PM View: | EXACT Sciences Corp. (EXAS) | 28-Feb-22 | Option Exercise | 29,887 | -- | -- | 3% 963.7K to 993.59K | |
| 25-Feb-22 6:40 PM View: | EXACT Sciences Corp. (EXAS) | 24-Feb-22 | Planned Option Sale | 27,126 | $70.10 | $1,901,530.00 | (3%) 990.83K to 963.7K | |
| 25-Feb-22 6:40 PM View: | EXACT Sciences Corp. (EXAS) | 23-Feb-22 | Option Exercise | 58,643 | -- | -- | 6% 932.18K to 990.83K | |
| 24-Feb-22 7:14 PM View: | EXACT Sciences Corp. (EXAS) | 23-Feb-22 | Planned Option Sale | 5,188 | $69.05 | $358,231.00 | (< 1%) 937.37K to 932.18K | |
| 24-Feb-22 7:14 PM View: | EXACT Sciences Corp. (EXAS) | 22-Feb-22 | Option Exercise | 10,373 | -- | -- | 1% 927.0K to 937.37K | |
| 16-Feb-22 8:08 PM View: | EXACT Sciences Corp. (EXAS) | 15-Feb-22 | Planned Option Sale | 14,409 | $79.55 | $1,146,240.00 | (2%) 941.4K to 926.99K | |
| 16-Feb-22 8:08 PM View: | EXACT Sciences Corp. (EXAS) | 14-Feb-22 | Option Exercise | 222,316 | $19.53 | $4,342,000.00 | 31% 719.08K to 941.4K | |
| 28-Jan-22 7:00 PM View: | Adaptive Biotechnologies Corp (ADPT) | 26-Jan-22 | Grant | 6,689 | -- | -- | 445% 1.5K to 8.19K | |
| 19-Jan-22 4:56 PM View: | EXACT Sciences Corp. (EXAS) | 14-Jan-22 | Grant | 6,407 | -- | -- | < 1% 712.66K to 719.07K | |
| 04-Jan-22 10:00 PM View: | Epizyme, Inc. (EPZM) | 31-Dec-21 | Grant | 6,000 | $2.50 | $15,000.00 | 25% 24.08K to 30.08K | (3%) |
| 03-Nov-21 5:01 PM View: | EXACT Sciences Corp. (EXAS) | 01-Nov-21 | Market Sale | 16,922 | $93.88 | $1,588,640.00 | (2%) 729.55K to 712.63K | (2%) |
| 05-Oct-21 5:26 PM View: | EXACT Sciences Corp. (EXAS) | 01-Oct-21 | Market Sale | 17,078 | $93.64 | $1,599,180.00 | (2%) 746.62K to 729.54K | < 1% |
| 01-Oct-21 4:30 PM View: | Epizyme, Inc. (EPZM) | 30-Sep-21 | Grant | 2,930 | $5.12 | $15,001.60 | 14% 21.15K to 24.08K | < 1% |
| 03-Sep-21 10:00 PM View: | EXACT Sciences Corp. (EXAS) | 01-Sep-21 | Market Sale | 18,978 | $104.42 | $1,981,680.00 | (2%) 765.59K to 746.61K | (< 1%) |
| 03-Sep-21 8:29 PM View: | Somalogic, Inc. (SLGC) | 01-Sep-21 | Acquisition (other) | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 01-Jul-21 4:15 PM View: | Epizyme, Inc. (EPZM) | 30-Jun-21 | Grant | 1,805 | $8.31 | $14,999.60 | 9% 19.34K to 21.15K | 0% |
| 15-Jun-21 4:35 PM View: | Epizyme, Inc. (EPZM) | 11-Jun-21 | Grant | 8,060 | -- | -- | 71% 11.28K to 19.34K | |
| 03-Jun-21 4:11 PM View: | EXACT Sciences Corp. (EXAS) | 01-Jun-21 | Market Sale (Planned) | 12,384 | $111.00 | $1,374,620.00 | (2%) 805.7K to 793.32K | 2% |